Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $94.1400 (0.57%) ($93.0200 - $94.7900) on Wed. Feb. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.43% (three month average) | RSI | 74 | Latest Price | $94.1400(0.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV advances 6.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(64%) SPLV(54%) DIA(53%) VYM(53%) IVE(52%) | Factors Impacting ABBV price | ABBV will decline at least -0.715% in a week (0% probabilities). VIXM(-37%) VXX(-14%) TLT(-14%) UUP(-1%) SHY(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.715% (StdDev 1.43%) | Hourly BBV | 1 () | Intraday Trend | 0.4% | | | |
|
5 Day Moving Average | $94.99(-0.89%) | 10 Day Moving Average | $93.32(0.88%) | 20 Day Moving Average | $88.69(6.14%) | To recent high | -3.7% | To recent low | 16.2% | Market Cap | $166.09b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |